# Cardiac Risk Assessment Using Standard of Care Versus CTA and Heart Flow FFRct

> **NCT04089969** · NA · WITHDRAWN · sponsor: **Corewell Health East**

## Conditions studied

- Coronary Artery Disease
- Acute Liver Failure
- Liver Transplant

## Interventions

- **DIAGNOSTIC_TEST:** CTA/FFRct
- **DIAGNOSTIC_TEST:** SOC cardiovascular evaluation

## Key facts

- **NCT ID:** NCT04089969
- **Lead sponsor:** Corewell Health East
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-06
- **Primary completion:** 2024-06
- **Final completion:** 2024-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Essential staff for study execution left the institution and no suitable replacement could be found.
- **Last updated:** 2023-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04089969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04089969, "Cardiac Risk Assessment Using Standard of Care Versus CTA and Heart Flow FFRct". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04089969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*